Harel Insurance Investments & Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $101K | Sell |
1,440
-4,910
| -77% | -$344K | ﹤0.01% | 315 |
|
2025
Q1 | $467K | Buy |
6,350
+823
| +15% | +$60.5K | 0.01% | 206 |
|
2024
Q4 | $362K | Buy |
+5,527
| New | +$362K | 0.01% | 173 |
|
2024
Q2 | – | Sell |
-753
| Closed | -$51K | – | 546 |
|
2024
Q1 | $51K | Buy |
753
+22
| +3% | +$1.49K | ﹤0.01% | 367 |
|
2023
Q4 | $49K | Sell |
731
-2,288
| -76% | -$153K | ﹤0.01% | 421 |
|
2023
Q3 | $204K | Sell |
3,019
-1,132
| -27% | -$76.5K | ﹤0.01% | 305 |
|
2023
Q2 | $294K | Buy |
+4,151
| New | +$294K | 0.01% | 265 |
|
2022
Q4 | – | Sell |
-1,006
| Closed | -$55K | – | 685 |
|
2022
Q3 | $55K | Buy |
1,006
+121
| +14% | +$6.62K | ﹤0.01% | 491 |
|
2022
Q2 | $58K | Buy |
+885
| New | +$58K | ﹤0.01% | 485 |
|
2022
Q1 | – | Sell |
-58
| Closed | -$3K | – | 710 |
|
2021
Q4 | $3K | Buy |
+58
| New | +$3K | ﹤0.01% | 716 |
|